iiinova — where your digital self keeps evolving

Jasmine Sethi @jasminenephro.bsky.social · 16/10/2025

🥸Kidney stones that require metabolic evaluation of patient academic.oup.com/pmj/article/...

010

Jasmine Sethi @jasminenephro.bsky.social · 14/10/2025

🧬Complement Pathways and Regulators in Kidney Ds doi.org/10.1093/ndt/... @hjanders.bsky.social

051

Jasmine Sethi @jasminenephro.bsky.social · 14/10/2025

😩Gout Management in CKD www.ajkd.org/article/S027... @ajkd.bsky.social

030

Reposted by Jasmine Sethi

Indian Society of Nephrology @isn-india.bsky.social · 18/08/2025

Claim your travel grant for #ISNCON25 ‼️ Submit your abstract here: isn-india.org/isn_registra... @jasminenephro.bsky.social @sayalibthakare.bsky.social @thisis-drgsp2.bsky.social @arvindcanchi.bsky.social

044

Jasmine Sethi @jasminenephro.bsky.social · 07/03/2025

🫘Non invasive biomarkers of Rejection pubmed.ncbi.nlm.nih.gov/39419272/ @ajkd.bsky.social

031

Jasmine Sethi @jasminenephro.bsky.social · 07/03/2025

🫘Renal Amyloidosis academic.oup.com/ndt/article-... @hjanders.bsky.social

042

Jasmine Sethi @jasminenephro.bsky.social · 22/02/2025

💊🫘Drugs to prevent CKD Progression doi.org/10.1093/ndt/... @hjanders.bsky.social

084

Reposted by Jasmine Sethi

Dr. Hardik Patel 🩺💉 @hardik4u24.bsky.social · 21/02/2025

🌟Beyond Testing—IgAN Trials Unveiled!-Must Read🌟 From #Sparsentan to #Iptacopan, innovative non-immunomodulatory & immunomodulatory therapies are transforming IgAN care!🎯 🔬 Excellent Trial insights by @Melgreux 📖 via @KidneyKolumns Jan25 #Nephrology #IgAN #ClinicalTrials

021

Jasmine Sethi @jasminenephro.bsky.social · 18/02/2025

🫘🎯Light chain Amyloidosis 😬Kidneys 🫘 and heart most commonly involved 🎯Mostly nephrotic range proteinuria @nejm.org www.nejm.org/doi/full/10....

030

Jasmine Sethi @jasminenephro.bsky.social · 17/02/2025

👍New Lupus Nephritis guidelines #ACR2024 🤘Major change-Triple therapy for induction ✅

0103

Jasmine Sethi @jasminenephro.bsky.social · 17/02/2025

🦠🫘Approach to BKV in kidney transplant recipients doi.org/10.1093/ndt/... @hjanders.bsky.social

041

Jasmine Sethi @jasminenephro.bsky.social · 17/02/2025

🤔🤔Ever heard of DMANDs-Disease modifying anti nephropathic drugs doi.org/10.1093/ndt/... @hjanders.bsky.social #Nephsky #Nephpearls

165

Jasmine Sethi @jasminenephro.bsky.social · 16/02/2025

🫘Hyperuricemia management in CKD ❌DO NOT use urate lowering drugs in CKD with asymptomatic Hyperuricemia @nephjc.bsky.social @kdigo.org #NephPearls #NephSky

0102

Jasmine Sethi @jasminenephro.bsky.social · 16/02/2025

🫘Approach to high flow hemodialysis vascular access #NephSky #Nephpearls doi.org/10.23876/j.k...

063

Reposted by Jasmine Sethi

Joel Topf @kidneyboy.bsky.social · 13/02/2025

KDIGO: Every CKD patient should be on a statin KDIGO ADPKD Guidelines

2154

Jasmine Sethi @jasminenephro.bsky.social · 12/02/2025

🤗🫘Great insights, inspiring discussions and amazing connections at ISN WCN @theisn.org @isn-india.bsky.social #ISNWCN

150

Jasmine Sethi @jasminenephro.bsky.social · 12/02/2025

🫘When to do kidney biopsy in diabetes academic.oup.com/ckj/advance-... @ckj-era.bsky.social

022

Jasmine Sethi @jasminenephro.bsky.social · 12/02/2025

📝Medical therapy in CKD-RAASi, SGLT2i , GLP1RA and Non steroidal MRA doi.org/10.1093/ndt/... @hjanders.bsky.social

032

Jasmine Sethi @jasminenephro.bsky.social · 10/12/2024

😎ADPKD bedside must know questions/pearls @isn-india.bsky.social social media Team has launched the clinical online bedside series 🎯Sharing some pearls from the first bedside @arvindcanchi.bsky.social @isn-india.bsky.social